Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0605
D

Failure to Conduct Gradual Dose Reduction for Psychotropic Medication

Simi Valley, California Survey Completed on 08-07-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to conduct a gradual dose reduction (GDR) for psychotropic medication for one resident. Observation showed the resident sleeping in bed during the day, and interview with a family member revealed concerns about the resident's medication regimen, specifically noting that the resident was sleeping during the day and awake at night. The family member was aware the resident was taking a sleeping pill but was unsure of the administration time. Record review indicated the resident had diagnoses including anxiety and traumatic brain injury and had an active order for Seroquel (Quetiapine Fumarate) 12.5 mg twice daily for psychosis manifested by agitation and aggression. Further review found that the facility was unable to provide monthly pharmacy medication reviews for three consecutive months, and there was no documentation of any gradual dose reduction attempts during that period. The facility's policies required GDRs for residents on psychotropic medications unless clinically contraindicated, and required documentation and action on pharmacy drug regimen review recommendations. The lack of GDR and missing documentation led to the resident potentially receiving unnecessary medication.

An unhandled error has occurred. Reload 🗙